Related Experiment Video
Updated: Mar 27, 2026

Imaging Calcium Dynamics in Subpopulations of Mouse Pancreatic Islet Cells
Published on: November 26, 2019
Reactive oxygen and nitrogen species disturb Ca(2+) oscillations in insulin-secreting MIN6 β-cells
Salvatore Antonucci1,2, Alessia Tagliavini3, Morten Gram Pedersen3
1a Department of Biomedical Sciences ; University of Padua ; Padua , Italy.
Abstract:
Disturbances in pulsatile insulin secretion and Ca(2+) oscillations in pancreatic β-cells are early markers of diabetes, but the underlying mechanisms are still incompletely understood. Reactive oxygen/nitrogen species (ROS/RNS) are implicated in reduced β-cell function, and ROS/RNS target several Ca(2+) pumps and channels. Thus, we hypothesized that ROS/RNS could disturb Ca(2+) oscillations and downstream insulin pulsatility. We show that ROS/RNS production by photoactivation of aluminum phthalocyanine chloride (AlClPc) abolish or accelerate Ca(2+) oscillations in the MIN6 β-cell line, depending on the amount of ROS/RNS. Application of the sarcoplasmic/endoplasmic reticulum Ca(2+) ATPase (SERCA) inhibitor thapsigargin modifies the Ca(2+) response to high concentrations of ROS/RNS. Further, thapsigargin produces effects that resemble those elicited by moderate ROS/RNS production. These results indicate that ROS/RNS interfere with endoplasmic reticulum Ca(2+) handling. This idea is supported by theoretical studies using a mathematical model of Ca(2+) handling adapted to MIN6 cells. Our results suggest a putative link between ROS/RNS and disturbed pulsatile insulin secretion.
Insights
Reactive oxygen/nitrogen species (ROS/RNS) disrupt calcium (Ca2+) oscillations in pancreatic beta cells, impacting insulin secretion. This study reveals ROS/RNS interfere with endoplasmic reticulum Ca2+ handling, linking them to diabetes pathogenesis.
Area of Science:
- Endocrinology
- Cell Biology
- Biochemistry
Background:
- Pulsatile insulin secretion and Ca2+ oscillations in pancreatic beta cells are crucial for glucose homeostasis.
- Disturbances in these processes are early indicators of diabetes.
- The role of reactive oxygen/nitrogen species (ROS/N) in beta cell dysfunction is increasingly recognized, with evidence suggesting they target key Ca2+ regulatory proteins.
Purpose of the Study:
- To investigate the hypothesis that ROS/RNS disrupt Ca2+ oscillations and subsequent insulin pulsatility.
- To elucidate the mechanisms by which ROS/RNS affect Ca2+ handling in pancreatic beta cells.
Main Methods:
- Utilized photoactivation of aluminum phthalocyanine chloride (AlClPc) to generate ROS/RNS in MIN6 beta cells.
- Applied the sarcoplasmic/endoplasmic reticulum Ca2+ ATPase (SERCA) inhibitor thapsigargin.
- Employed a mathematical model of Ca2+ handling adapted to MIN6 cells for theoretical analysis.
Main Results:
- ROS/RNS, depending on concentration, either abolished or accelerated Ca2+ oscillations in MIN6 cells.
- Thapsigargin modulated the cellular response to high ROS/RNS concentrations.
- Thapsigargin's effects mimicked those of moderate ROS/RNS exposure, suggesting interference with endoplasmic reticulum Ca2+ handling.
Conclusions:
- ROS/RNS directly impact Ca2+ oscillation dynamics in pancreatic beta cells.
- Endoplasmic reticulum Ca2+ handling is a key target for ROS/RNS-induced beta cell dysfunction.
- These findings establish a potential link between ROS/RNS and the disturbed pulsatile insulin secretion observed in diabetes.
Related Concept Videos
Feedback Regulation of Calcium Concentration
Various transmembrane receptors, such as G protein-coupled receptors (GPCRs), elicit a response to extracellular signals by increasing cytosolic calcium. Activated GPCRs...
Insulin Secretory Vesicles
Glucose Homeostasis: Pancreatic Islets and Insulin Secretion
Insulin and C-peptide are...
Hormones Regulating Blood Glucose
In addition to accelerating glucose uptake and utilization, insulin has...
Skeleton and Calcium Homeostasis
Overview of Secretory Vesicles
Various proteins regulate the aggregation of molecules inside the secretory vesicles. Chromogranins...

